GPL Holdings, Inc. (GPLL)
Oxford Ledge is still expanding full research coverage of GPLL. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
GPL Holdings is a biopharmaceutical company focused on developing new therapies and providing low-cost pharmaceuticals.
SEC filings
- 8-K 4.01; Financial statements and exhibits 2024-05-10
- 10-Q Quarterly financial report (unaudited) 2024-04-26
- 10-K Annual financial report with audited statements 2024-03-18
- 8-K Entry into material agreement 2023-08-18
- 10-Q Quarterly financial report (unaudited) 2023-06-20
Source: SEC EDGAR.
- Open GPLL in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.